Literature DB >> 9439144

Carisoprodol: a drug of continuing abuse.

R R Reeves1, H B Pinkofsky, O S Carter.   

Abstract

Carisoprodol (Soma) is a noncontrolled, skeletal-muscle relaxant whose active metabolite is meprobamate. Despite previous indications that the drug may be abused, it continues to be widely prescribed for musculoskeletal conditions involving muscle spasm. Presented here are three cases demonstrating patterns of carisoprodol abuse not previously reported. Carisoprodol usage should be limited to short-term treatment. Patients for whom carisoprodol is prescribed are at risk for meprobamate dependence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9439144     DOI: 10.7556/jaoa.1997.97.12.723

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  4 in total

1.  Carisoprodol pharmacokinetics and distribution in the nucleus accumbens correlates with behavioral effects in rats independent from its metabolism to meprobamate.

Authors:  Theresa M Carbonaro; Vien Nguyen; Michael J Forster; Michael B Gatch; Laszlo Prokai
Journal:  Neuropharmacology       Date:  2020-05-29       Impact factor: 5.250

2.  Characterizing the subjective and psychomotor effects of carisoprodol in healthy volunteers.

Authors:  James P Zacny; Judith A Paice; Dennis W Coalson
Journal:  Pharmacol Biochem Behav       Date:  2011-08-23       Impact factor: 3.533

3.  Abuse Potential of Soma: the GABA(A) Receptor as a Target.

Authors:  Lorie A Gonzalez; Michael B Gatch; Michael J Forster; Glenn H Dillon
Journal:  Mol Cell Pharmacol       Date:  2009-01-01

4.  Carisoprodol-mediated modulation of GABAA receptors: in vitro and in vivo studies.

Authors:  Lorie A Gonzalez; Michael B Gatch; Cynthia M Taylor; Cathy L Bell-Horner; Michael J Forster; Glenn H Dillon
Journal:  J Pharmacol Exp Ther       Date:  2009-02-24       Impact factor: 4.030

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.